Universita degli Studi G. D'Annunzio -CeSi-MeT
About Universita degli Studi G. D'Annunzio -CeSi-MeT
D'Annunzio University is a public research university located in Chieti and Pescara, neighbouring cities in the region of Abruzzo, Italy.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Universita degli Studi G. D'Annunzio -CeSi-MeT
During the past decade, Universita degli Studi G. D'Annunzio -CeSi-MeT conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Universita degli Studi G. D'Annunzio -CeSi-MeT
According to Clinical.Site data, the most researched conditions in "Universita degli Studi G. D'Annunzio -CeSi-MeT" are
"Dermatitis, Atopic" (2 trials), "Dermatitis" (1 trials), "Eczema" (1 trials), "Genetic Diseases, Inborn" (1 trials) and "Hypersensitivity" (1 trials). Many other conditions were trialed in "Universita degli Studi G. D'Annunzio -CeSi-MeT" in a lesser frequency.
Clinical Trials Intervention Types at Universita degli Studi G. D'Annunzio -CeSi-MeT
Most popular intervention types in "Universita degli Studi G. D'Annunzio -CeSi-MeT" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "PF-04965842 100 mg" (1 trials) and "PF-04965842 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universita degli Studi G. D'Annunzio -CeSi-MeT
The vast majority of trials in "Universita degli Studi G. D'Annunzio -CeSi-MeT" are
2 trials for "All" genders.
Clinical Trials Status at Universita degli Studi G. D'Annunzio -CeSi-MeT
Currently, there are NaN active trials in "Universita degli Studi G. D'Annunzio -CeSi-MeT".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Universita degli Studi G. D'Annunzio -CeSi-MeT,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universita degli Studi G. D'Annunzio -CeSi-MeT, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".